These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17953248)

  • 1. Gene expression patterns in hepatic tissue and visceral adipose tissue of patients with non-alcoholic fatty liver disease.
    Baranova A; Schlauch K; Elariny H; Jarrar M; Bennett C; Nugent C; Gowder SJ; Younoszai Z; Collantes R; Chandhoke V; Younossi ZM
    Obes Surg; 2007 Aug; 17(8):1111-8. PubMed ID: 17953248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Adipose Tissue Inflammation With Histologic Severity of Nonalcoholic Fatty Liver Disease.
    du Plessis J; van Pelt J; Korf H; Mathieu C; van der Schueren B; Lannoo M; Oyen T; Topal B; Fetter G; Nayler S; van der Merwe T; Windmolders P; Van Gaal L; Verrijken A; Hubens G; Gericke M; Cassiman D; Francque S; Nevens F; van der Merwe S
    Gastroenterology; 2015 Sep; 149(3):635-48.e14. PubMed ID: 26028579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of genes for microRNA-processing enzymes is altered in advanced non-alcoholic fatty liver disease.
    Sharma H; Estep M; Birerdinc A; Afendy A; Moazzez A; Elariny H; Goodman Z; Chandhoke V; Baranova A; Younossi ZM
    J Gastroenterol Hepatol; 2013 Aug; 28(8):1410-5. PubMed ID: 23663110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of miRNAs in the visceral adipose tissue of patients with non-alcoholic fatty liver disease.
    Estep M; Armistead D; Hossain N; Elarainy H; Goodman Z; Baranova A; Chandhoke V; Younossi ZM
    Aliment Pharmacol Ther; 2010 Aug; 32(3):487-97. PubMed ID: 20497147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body mass index and the visceral adipose tissue expression of IL-6 and TNF-alpha are associated with the morphological severity of non-alcoholic fatty liver disease in individuals with class III obesity.
    Jorge ASB; Andrade JMO; Paraíso AF; Jorge GCB; Silveira CM; de Souza LR; Santos EP; Guimaraes ALS; Santos SHS; De-Paula AMB
    Obes Res Clin Pract; 2018; 12(Suppl 2):1-8. PubMed ID: 27083404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic gene expression in patients with obesity-related non-alcoholic steatohepatitis.
    Younossi ZM; Gorreta F; Ong JP; Schlauch K; Del Giacco L; Elariny H; Van Meter A; Younoszai A; Goodman Z; Baranova A; Christensen A; Grant G; Chandhoke V
    Liver Int; 2005 Aug; 25(4):760-71. PubMed ID: 15998427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptomic differences in intra-abdominal adipose tissue in extremely obese adolescents with different stages of NAFLD.
    Sheldon RD; Kanosky KM; Wells KD; Miles L; Perfield JW; Xanthakos S; Inge TH; Rector RS
    Physiol Genomics; 2016 Dec; 48(12):897-911. PubMed ID: 27764764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there a role for neuregulin 4 in human nonalcoholic fatty liver disease?
    De Munck TJI; Boesch M; Verhaegh P; Masclee AAM; Jonkers D; van Pelt JF; du Plessis J; Korf H; Nevens F; Koek GH; Van der Merwe S; Verbeek J
    PLoS One; 2021; 16(5):e0251822. PubMed ID: 33989346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of inflammatory and angiogenic factors in patients with non-alcoholic fatty liver disease.
    Coulon S; Francque S; Colle I; Verrijken A; Blomme B; Heindryckx F; De Munter S; Prawitt J; Caron S; Staels B; Van Vlierberghe H; Van Gaal L; Geerts A
    Cytokine; 2012 Aug; 59(2):442-9. PubMed ID: 22658783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression of leptin, resistin, and adiponectin in the white adipose tissue of obese patients with non-alcoholic fatty liver disease and insulin resistance.
    Baranova A; Gowder SJ; Schlauch K; Elariny H; Collantes R; Afendy A; Ong JP; Goodman Z; Chandhoke V; Younossi ZM
    Obes Surg; 2006 Sep; 16(9):1118-25. PubMed ID: 16989692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis and insulin resistance in liver and peripheral tissues of morbidly obese patients is associated with different stages of non-alcoholic fatty liver disease.
    Ferreira DM; Castro RE; Machado MV; Evangelista T; Silvestre A; Costa A; Coutinho J; Carepa F; Cortez-Pinto H; Rodrigues CM
    Diabetologia; 2011 Jul; 54(7):1788-98. PubMed ID: 21455726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of cytokine signaling genes in morbidly obese patients with non-alcoholic steatohepatitis and hepatic fibrosis.
    Estep JM; Baranova A; Hossain N; Elariny H; Ankrah K; Afendy A; Chandhoke V; Younossi ZM
    Obes Surg; 2009 May; 19(5):617-24. PubMed ID: 19280268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visceral adipose tissue visfatin in nonalcoholic fatty liver disease.
    Gaddipati R; Sasikala M; Padaki N; Mukherjee RM; Sekaran A; Jayaraj-Mansard M; Rabella P; Rao-Guduru V; Reddy-Duvvuru N
    Ann Hepatol; 2010; 9(3):266-70. PubMed ID: 20720266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systems biology approach to the pathogenesis of obesity-related nonalcoholic fatty liver disease using reverse phase protein microarrays for multiplexed cell signaling analysis.
    Calvert VS; Collantes R; Elariny H; Afendy A; Baranova A; Mendoza M; Goodman Z; Liotta LA; Petricoin EF; Younossi ZM
    Hepatology; 2007 Jul; 46(1):166-72. PubMed ID: 17596878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced A-FABP expression in visceral fat: potential contributor to the progression of NASH.
    Yoon MY; Sung JM; Song CS; Lee WY; Rhee EJ; Shin JH; Yoo CH; Chae SW; Kim JY; Jin W; Cho YK
    Clin Mol Hepatol; 2012 Sep; 18(3):279-86. PubMed ID: 23091808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma visfatin levels and gene expression in morbidly obese women with associated fatty liver disease.
    Auguet T; Terra X; Porras JA; Orellana-Gavaldà JM; Martinez S; Aguilar C; Lucas A; Pellitero S; Hernández M; Del Castillo D; Richart C
    Clin Biochem; 2013 Feb; 46(3):202-8. PubMed ID: 23174488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of cell death mechanisms and fibrosis in visceral white adipose tissue with pathological alterations in the liver of morbidly obese patients with NAFLD.
    Leven AS; Gieseler RK; Schlattjan M; Schreiter T; Niedergethmann M; Baars T; Baba HA; Özçürümez MK; Sowa JP; Canbay A
    Adipocyte; 2021 Dec; 10(1):558-573. PubMed ID: 34743657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inhibitory effect of genistein on hepatic steatosis is linked to visceral adipocyte metabolism in mice with diet-induced non-alcoholic fatty liver disease.
    Kim MH; Kang KS; Lee YS
    Br J Nutr; 2010 Nov; 104(9):1333-42. PubMed ID: 20687969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adipocytokine expression associated with miRNA regulation and diagnosis of NASH in obese patients with NAFLD.
    Estep JM; Goodman Z; Sharma H; Younossi E; Elarainy H; Baranova A; Younossi Z
    Liver Int; 2015 Apr; 35(4):1367-72. PubMed ID: 24684403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Body Mass Index, Metabolic Health and Adipose Tissue Inflammation on the Severity of Non-alcoholic Fatty Liver Disease in Bariatric Surgical Patients: a Prospective Study.
    Ooi GJ; Burton PR; Bayliss J; Raajendiran A; Earnest A; Laurie C; Kemp WW; McLean CA; Roberts SK; Watt MJ; Brown WA
    Obes Surg; 2019 Jan; 29(1):99-108. PubMed ID: 30229460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.